NYSEARCA:FBT First Trust NYSE Arca Biotechnology Index Fund (FBT) Price, Holdings, & News $175.52 +2.43 (+1.40%) As of 03:24 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get FBT alerts:Sign Up Key Stats Today's Range$174.01▼$176.4250-Day Range$158.95▼$174.3252-Week Range$141.38▼$183.60Volume13,319 shsAverage Volume21,907 shsMarket Capitalization$1.09 billionAssets Under Management$1.06 billionDividend Yield0.67%Net Expense Ratio0.54%Aggregate RatingModerate Buy ETF Overview The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust. Read More First Trust NYSE Arca Biotechnology Index Fund ExpensesTypeFBTHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.40%0.56%0.56%0.51%0.53%Other Expenses0.14%0.47%0.56%0.59%0.56%Total Expense0.54%0.75%0.76%0.74%0.73%Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%Net Expense0.54%0.60%0.63%0.58%0.60% Receive FBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter. Email Address FBT ETF News HeadlinesFBT: This 30-Stock Biotech ETF Isn't Worth The Risk TodayMay 18, 2025 | seekingalpha.comFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationApril 17, 2025 | uk.investing.comThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening RIGHT NOW—this project is poised to see massive moves.... The smart money is already positioning.August 22 at 2:00 AM | Crypto 101 Media (Ad)First Trust Announces Completion of MergersMay 6, 2024 | tmcnet.comFirst Trust NYSE Arca Biotechnology Index Fund (FBT)March 31, 2024 | finance.yahoo.comClosing Bell: First Trust NYSE Arca Biotechnology ETF up on Friday (FBT)January 6, 2024 | theglobeandmail.comSee More Headlines FBT ETF - Frequently Asked Questions How have FBT shares performed this year? First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $166.21 at the start of the year. Since then, FBT stock has increased by 5.3% and is now trading at $174.94. Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders? Top institutional shareholders of First Trust NYSE Arca Biotechnology Index Fund include Kingstone Capital Partners Texas LLC (247.16%), Bank of America Corp DE (3.11%), Raymond James Financial Inc. (2.33%) and Envestnet Asset Management Inc. (1.94%). How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund? Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own? Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust NYSE Arca Biotechnology Index Fund investors own include DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), AU Optronics (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Fund Details IssuerFirst Trust Fund NameFirst Trust NYSE Arca Biotechnology Index Fund Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:FBT Inception Date6/19/2006 Fund ManagerDaniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE Arca Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings31 Fund Statistics Assets Under Management$1.06 billion Average Daily Volume$13.47 thousand Discount/Premium-0.18% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableOptionable Options Volume1 Put Options2 Call Options1 Short Interest5,400 shs Miscellaneous Outstanding Shares6,200,000Beta0.79 Creation Unit50,000 Creation Fee$500.00 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Top 10 FBT HoldingsBeOne Medicines (NASDAQ:ONC)Holding Weight: 3.91%ACADIA Pharmaceuticals (NASDAQ:ACAD)Holding Weight: 3.72%Illumina (NASDAQ:ILMN)Holding Weight: 3.70%Genmab A/S (NASDAQ:GMAB)Holding Weight: 3.67%Gilead Sciences (NASDAQ:GILD)Holding Weight: 3.56%argenex (NASDAQ:ARGX)Holding Weight: 3.55%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.51%Amgen (NASDAQ:AMGN)Holding Weight: 3.49%Mettler-Toledo International (NYSE:MTD)Holding Weight: 3.47%United Therapeutics (NASDAQ:UTHR)Holding Weight: 3.46%Full Holdings DetailsFBT Sector ExposureFBT Industry Exposure This page (NYSEARCA:FBT) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.